Not only is Wegovy extremely effective (people lose about 15% of their body weight in a year), it also appears to have many ...

For patients with previously treated EGFR-mutated NSCLC, a new BLA has been submitted to the FDA seeking the accelerated ...

Lung cancer is the top cause of cancer-related deaths globally, more prevalent in men, and ranks third among women. Both ...

On the wall of Dian Yang's office hangs a painting of a "Pandora's box of cancer" being opened with a molecular key. From ...

Researchers found that the COVID-19 virus triggers immune changes that may one day be harnessed to help fight cancer.

Efti + KEYTRUDA combo shows strong efficacy for NSCLC patients in Immutep's phase 1 study. Read why IMMP stock may see upside ...

Clinical trials are a significant part of the drug development cycle. However, the process has remained unchanged in recent ...

Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.

Male sex was also shown to be an independent risk factor for longer hospital stays and increased hospitalization costs at ...

Bristol Myers Squibb on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended expanded approval of its Augtyro cancer drug in a pair of indications.

VEGF bispecifics. | Merck and BioNTech are buying Chinese biotechs to gain PD-(L)1/VEGF bispecifics. AstraZeneca's CEO argued ...

I-Mab, a U.S.-based, global biotech company, exclusively focused on the development of highly differentiated immunotherapies ...